Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

Voorberg, J; Roelse, J; Koopman, R; Büller, H; Berends, F; ten Cate, J W; Mertens, K; van Mourik, J A · Lancet · 1994

case_series · Level IV

Where this comes from

Abstract

Abnormal coagulation factor V may underlie the thrombotic events associated with resistance to activated protein C (APC). We analysed 27 consecutive patients with documented idiopathic (recurrent) thromboembolism for the occurrence of point mutations within the APC sensitive regions of blood coagulation factor V. In 10 patients we observed a single basepair mutation resulting in a substitution of Arg506 to Gln. This mutation was significantly linked to in-vitro resistance to APC in these subjects. This mutation at Arg506 of factor V may form the molecular basis for the thrombotic events associated with APC resistance.

Medical subject headings